欢迎您加入月均活跃用户100万+的科研社区!如您有任何系统建议,请点此洽谈。
;如有合作推广需求,请近期推荐: | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 | 新 已发表SCI?是时候来Springer出书了! |
![]() |
基本信息 | 登录收藏 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | TECHNOLOGY IN CANCER RESEARCH & TREATMENT TECHNOL CANCER RES T (此期刊被最新的JCR期刊SCIE收录) LetPub评分 5.5
57人评分
我要评分
声誉 6.4 影响力 4.2 速度 8.0 | |||||||||||||||||||||
期刊ISSN | 1533-0346 | ![]() 蝌蝌APP,让您与同行交流更轻松
![]() | ||||||||||||||||||||
E-ISSN | 1533-0338 | |||||||||||||||||||||
2024-2025最新影响因子 (数据来源于搜索引擎) | 2.8 点击查看影响因子趋势图 | |||||||||||||||||||||
实时影响因子 | 截止2025年5月19日:2.778 | |||||||||||||||||||||
2024-2025自引率 | 3.60%点击查看自引率趋势图 | |||||||||||||||||||||
五年影响因子 | 2.5 | |||||||||||||||||||||
JCI期刊引文指标 | 0.55 | |||||||||||||||||||||
h-index | 56 | |||||||||||||||||||||
CiteScore ( 2025年最新版) |
| |||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||
期刊官方网站 | http://tct.sagepub.com/ | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
期刊投稿网址 | https://us.sagepub.com/en-us/nam/technology-in-cancer-research-treatment/journal202330#submission-guidelines | |||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足TECHNOLOGY IN CANCER RESEARCH & TREATMENT的语言要求,还能让TECHNOLOGY IN CANCER RESEARCH & TREATMENT编辑和审稿人得到更好的审稿体验,让稿件最大限度地被TECHNOLOGY IN CANCER RESEARCH & TREATMENT编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢(1篇) 。
提交文稿 | |||||||||||||||||||||
是否OA开放访问 | No | |||||||||||||||||||||
通讯方式 | ADENINE PRESS, 2066 CENTRAL AVE, SCHENECTADY, USA, NY, 12304 | |||||||||||||||||||||
出版商 | SAGE Publications Inc. | |||||||||||||||||||||
涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||
出版国家或地区 | UNITED STATES | |||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||
出版周期 | Bimonthly | |||||||||||||||||||||
出版年份 | 2002 | |||||||||||||||||||||
年文章数 | 199点击查看年文章数趋势图 | |||||||||||||||||||||
Gold OA文章占比 | 94.69% | |||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 87.94% | |||||||||||||||||||||
WOS期刊JCR分区 ( 2024-2025年最新版) | WOS分区等级:2区
| |||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||
中国科学院期刊分区 ( 2025年3月最新升级版) | 点击查看中国科学院期刊分区趋势图
| |||||||||||||||||||||
中国科学院期刊分区 ( 2023年12月升级版) |
| |||||||||||||||||||||
中国科学院期刊分区 ( 2022年12月旧的升级版) |
| |||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1533-0346%5BISSN%5D | |||||||||||||||||||||
平均审稿速度 | 网友分享经验: 平均2月 | |||||||||||||||||||||
平均录用比例 | 网友分享经验: 约80% | |||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在TECHNOLOGY IN CANCER RESEARCH & TREATMENT顺利发表。
快看看作者怎么说吧:服务好评 论文致谢(1篇) 。 提交文稿 | |||||||||||||||||||||
期刊常用信息链接 |
|
|
|
中国学者近期发表的论文 | |
1. | Streamlining Thoracic Radiotherapy Quality assurance: One-Class Classification for Automated OAR Contour Assessment Author: Zhao, Yihao; Yuan, Cuiyun; Liang, Ying; Li, Yang; Li, Chunxia; Zhao, Man; Hu, Jun; Zhong, Ningze; Liu, Wei; Liu, Chenbin Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 2025; Vol. 24, Issue , pp. -. DOI: 10.1177/15330338251345895 PubMed DOI |
2. | Bolus Use in Postmastectomy Radiation Therapy for Breast Cancer: A Systematic Literature Review Author: Li, Fengyan; Hu, Wendie; Li, Hanzong; Li, Bohan; Wang, Yaxue Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 2025; Vol. 24, Issue , pp. -. DOI: 10.1177/15330338251344521 PubMed DOI |
3. | Pretreatment CT-Based Machine Learning Radiomics Model Predicts Response in Inoperable Stage III NSCLC Treated with Concurrent Radiochemotherapy Plus PD-1 Inhibitors Author: Li, Ya; Zhang, Min; Hu, Yong; Du, Bo; Mo, Youlong; He, Tianchu; Zhao, Mingdan; Li, Benlan; Xia, Ji; Huang, Zhongjun; Lu, Fangyang; Huang, Zhen; Lu, Bing; Peng, Jie Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 2025; Vol. 24, Issue , pp. -. DOI: 10.1177/15330338251351109 PubMed DOI |
4. | Central-boost Ablative Radiation Therapy for Solid Tumors: Study Protocol of a Single-arm, Phase II Trial (CBART) Author: Jiang, Lingong; Cao, Yangsen; Yin, Xiaolan; Yu, Chunshan; Ye, Yusheng; Zhu, Xiaofei; Zhang, Huojun Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 2025; Vol. 24, Issue , pp. -. DOI: 10.1177/15330338251350833 PubMed DOI |
5. | Effect of the Residual Errors on the Dose for Left-Sided Breast Cancer Radiotherapy After Translation Error Correction Based on CBCT Author: Wang, Ya; Zeng, Lu; Gong, Pan; Liu, Denghong; Meng, Qianqian; Shen, Konglong; Liu, Zhihui; Zhong, Renming Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 2025; Vol. 24, Issue , pp. -. DOI: 10.1177/15330338251338489 PubMed DOI |
6. | Ensemble Machine Learning Classifiers Combining CT Radiomics and Clinical-Radiological Features for Preoperative Prediction of Pathological Invasiveness in Lung Adenocarcinoma Presenting as Part-Solid Nodules: A Multicenter Retrospective Study Author: Li, Yunhua; Ding, Jianbang; Wu, Kun; Qi, Wanyin; Lin, Shanyue; Chen, Gangwen; Zuo, Zhichao Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 2025; Vol. 24, Issue , pp. -. DOI: 10.1177/15330338251351365 PubMed DOI |
7. | Efficacy and Safety of Poly (ADP-Ribose) Polymerase Inhibitors in Combination with Chemotherapy for Advanced Breast Cancer: A Systematic Review and Meta-Analysis Author: Duan, Qiuhua; Feng, Yue; Cao, Lichen; Hu, Lijun; Wang, Jianlin; Sun, Fei; Meng, Qinghong; Zhou, Mengyun; Yu, Jingping; Gao, Haiyan Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 2025; Vol. 24, Issue , pp. -. DOI: 10.1177/15330338251350630 PubMed DOI |
8. | 'Line' Constraints Optimization for Improved Dose Distribution in Locally Recurrent Nasopharyngeal Carcinoma Using Knowledge-Based Planning Author: Yu, Xiaoli; Wang, Yixuan; Wang, Mingli; Gu, Huikuan; Yang, Xin; Hu, Jiang Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 2025; Vol. 24, Issue , pp. -. DOI: 10.1177/15330338251351535 PubMed DOI |
9. | Multimodal Model for Non-Invasive Detection of DRD2, SSTR2 and ESR1 Receptor Profiling in Pituitary Neuroendocrine Tumors: A Retrospective Study Author: Lu, Jianglong; Wang, Xianpeng; Jin, Jinghao; Xu, Fanjie; Tang, Runhua; Han, Cheng; Wu, Zerui; Su, Zhipeng; Guo, Yuhang Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 2025; Vol. 24, Issue , pp. -. DOI: 10.1177/15330338251353305 PubMed DOI |
10. | Drug Delivery System for Cancer Immunotherapy: Potential Roles, Challenge and Recent Advances Author: Lin, Zi-Yue; Song, Qian; Xu, Kai Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 2025; Vol. 24, Issue , pp. -. DOI: 10.1177/15330338251338390 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2025 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室